Merck and Daiichi Sankyo Report the Initiation of P-III (IDeate-Lung02) Study of Ifinatamab Deruxtecan to Treat Small Cell Lung Ca...
Shots: The companies have dosed the first patient in the P-III (
ALX Oncology Provides Update on P-II (ASPEN-06) Study of Evorpacept to Treat Gastric Cancer
Shots: ALX Oncology reported topline results from the P-II (
BioNTech Reports Topline Data from P-II Study of BNT111 to Treat Advanced Melanoma Patients
Shots: The P-II Study assessed BNT111 + Libtayo (cemiplimab) as a combination and...
AstraZeneca Provides Update on P-III (AMPLIFY) Trial of Calquence for Treating Chronic Lymphocytic Leukemia
Shots: The P-III (AMPLIFY) study is assessing the safety & efficacy of Calquen...
Calliditas Reports Results from P-IIb (TRANSFORM) Study of Setanaxib for Treating Primary Biliary Cholangitis
Shots: Calliditas reported topline results from P-IIb (TRANSFORM) study assessing...
